Catalyst Wire Dossier Catalyst Wire Dossier

Fluzopalil

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluzopalil, covering 2021-06-21 to 2021-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Fluzopalil in Combination With Anlotinib for Extensive Small-cell Lung Cancer [Phase 2]

See pricing